Emerald Insights Blog Resources

β2 Adrenergic Receptor

Structure Notes PDB Resolution [A] Reference
b2AR365-Fab5 complex 2R4S, 2R4R 3.4 / 3.4 Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, & Kobilka BK (2007). Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450:383-387.
Complex with Carazolol ligand and bound Cholesterol; T4 lysozyme fusion in 3rd intracellular loop 2RH1 2.4 Cherezov et al. (2007). High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science  318:1258-1265
T4 lysozyme fusion in 3rd intracellular loop, bound cholesterol 3D4S 2.8 Hanson et al., (2008)
A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure 16: 897-905
methylated receptor 3KJ6 3.4 Bokoch et al., (2010) Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.
(2010) Nature 463: 108-112
T4 lysozyme fusion in 3rd intracellular loop, bound cholesterol, mutations: E122W, N187E, C1054T, C1097A; inverse agonist ICI 118,551 3NY8 2.84 To be Published: Crystal structure of the human beta2 adrenergic receptor in complex with the inverse agonist ICI 118,551
T4 lysozyme fusion in 3rd intracellular loop, bound cholesterol, mutations: E122W, N187E, C1054T, C1097A; Timolol 3NY9 2.48 To be published: Crystal structure of the human beta2 adrenergic receptor in complex with a novel inverse agonist
T4 lysozyme fusion in 3rd intracellular loop, bound cholesterol, mutations: E122W, N187E, C1054T, C1097A; antagonist alprenolol 3NYA 3.16 Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography
agonist-occupied β2 adrenergic receptor (active) in complex with the (nucleotide free) Gs heterotrimer 3SN6 3.2 Rasmussen et al.
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Nature (2011)